UK markets closed

REMSleep Holdings, Inc. (RMSL)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0169+0.0002 (+0.90%)
As of 03:02PM EDT. Market open.
Full screen
Loading interactive chart…
  • GlobeNewswire

    REMSleep Holdings Patent Status

    CLEARWATER, FL, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - REMSleep Holdings, Inc. (OTCQB: RMSL) is awarded new patent. Dear Mr. Thomas Jackson Wood: I am writing to provide you a copy of the electronically granted patent titled Sleep Apnea Cannula and Nasal Pillows Device. Design patents expire 15 years from the issue date. Starting now, and lasting until expiration of the patent, the Firm recommends marking products that embody the disclosed invention using the patent number. The ma

  • GlobeNewswire

    REMSleep Holdings Shareholder Update

    CLEARWATER, FL, March 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - REMSleep Holdings, Inc. (OTC PINK: RMSL) gives an update on FDA process and REMSleep status. We have had numerous inquiries asking for REMSleep regulatory status update. REMSleep was asked to answer questions and perform added shelf-life testing. We have initiated the shelf-life testing and are waiting on results. We hope to get test results in the next six weeks. Then we have to resubmit the results. We believe we submitted t

  • GlobeNewswire

    Remsleep Holdings Inc.'s DeltaWave Mask has received questions from FDA regarding 510k submission (K233415)

    TAMPA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to Obstructive Sleep Apnea (OSA) has received a response to the company’s 510(K) submission K233415. The agency has determined that additional information is required. The agency has asked for additional information regarding Administrative Information, Device Description, Substantial Equivalence (SE), Labeling, Biocompat